Thyrocare Technologies Ltd. Thyrocare Tech.
Thyrocare Tech.
Thyrocare Technologies Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
| Ex-Date | Purpose |
|---|---|
08-05-2021 | Employees Stock Option Plan & Audited Results & Final Dividend |
12-08-2021 | Quarterly Results |
13-11-2021 | Quarterly Results |
12-02-2022 | Quarterly Results |
29-04-2022 | Employees Stock Option Plan & Dividend & Audited Results |
01-08-2022 | Quarterly Results |
11-11-2022 | Quarterly Results |
03-02-2023 | Quarterly Results |
07-04-2023 | Interim Dividend |
23-05-2023 | Audited Results |
01-08-2023 | Quarterly Results |
31-10-2023 | Quarterly Results |
01-02-2024 | Quarterly Results |
23-10-2024 | Quarterly Results |
23-01-2025 | Quarterly Results |
23-04-2025 | Final Dividend & Audited Results |
23-07-2025 | Quarterly Results |
14-10-2025 | Quarterly Results & Interim Dividend & Bonus issue |
28-01-2026 | Quarterly Results |
07-05-2026 | Final Dividend & Audited Results |
23-07-2026 | Quarterly Results |
29-10-2026 | Quarterly Results |
News
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. reports Profit after tax of Rs 481.30 Mln, in the September 2026 quarter
Thyrocare Technologies informs about newspaper publication
Thyrocare Technologies informs about disclosures
Thyrocare Technologies informs about SAST
Thyrocare Technologies informs about disclosure
Thyrocare Technologies’ promoter sells 9.90% stake
Docon Technologies has sold the stake through open market transactions worth Rs 985.86 crore
Thyrocare Technologies informs about disclosure
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. reports Profit after tax of Rs 501.70 Mln, in the June 2026 quarter
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. reports Profit after tax of Rs 435.80 Mln, in the March 2026 quarter
Thyrocare Technologies moves up on making additional investment in Thyrocare Tanzania
The capital infusion in Thyrocare Tanzania has been made to facilitate its business operations and working capital requirements
Thyrocare Technologies makes additional investment in Thyrocare Tanzania
The capital infusion in Thyrocare Tanzania has been made to facilitate its business operations and working capital requirements
Thyrocare Tech. - Quaterly Results
Thyrocare Technologies informs about investor presentation
Thyrocare Tech. reports Profit after tax of Rs 261.50 Mln, in the December 2025 quarter
Thyrocare Technologies informs about change in management
Thyrocare Technologies informs about appointment of COO
Thyrocare Technologies informs about disclosure
Thyrocare Technologies informs about disclosure
Thyrocare Technologies informs about allotment of bonus equity shares
Thyrocare Technologies informs about change in management
Thyrocare Technologies informs about disclosure
Thyrocare Technologies gains on reporting 80% rise in Q2 consolidated net profit
The consolidated total income of the company increased by 22.01% at Rs 219.58 crore for Q2FY26
Thyrocare Technologies reports 80% rise in Q2 consolidated net profit
The consolidated total income of the company increased by 22.01% at Rs 219.58 crore for Q2FY26
Thyrocare Tech. - Quaterly Results
Thyrocare Technologies informs about press release
Thyrocare Tech. reports Profit after tax of Rs 430.30 Mln, in the September 2025 quarter
Thyrocare Technologies informs about disclosure
Thyrocare Technologies informs about press release
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. reports Profit after tax of Rs 360.50 Mln, in the June 2025 quarter
Thyrocare Technologies informs about allotment of equity shares
Thyrocare Technologies informs about press release
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. reports Profit after tax of Rs 219.50 Mln, in the March 2025 quarter
Thyrocare Technologies jumps on making additional equity investment in Thyrocare Laboratories (Tanzania)
The equity infusion in the JV company has been made to facilitate its business operations and working capital requirements
Thyrocare Technologies makes additional equity investment in Thyrocare Laboratories (Tanzania)
The equity infusion in the JV company has been made to facilitate its business operations and working capital requirements
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. reports Profit after tax of Rs 191.00 Mln, in the December 2024 quarter
Thyrocare Tech. - Quaterly Results
Thyrocare Technologies gains on making another equity investment in Thyrocare Laboratories
The Joint Venture Company’s business is similar to the Company’s main line of business viz. diagnostic and healthcare services
Thyrocare Technologies makes another equity investment in Thyrocare Laboratories
The Joint Venture Company’s business is similar to the Company’s main line of business viz. diagnostic and healthcare services
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. reports Profit after tax of Rs 295.90 Mln, in the September 2024 quarter
Thyrocare Technologies jumps on completing acquisition of 100% stake in Think Health
Consequently, Think Health has become wholly-owned subsidiary company of Thyrocare with effective from February 27, 2024
Thyrocare Technologies completes acquisition of 100% stake in Think Health
Consequently, Think Health has become wholly-owned subsidiary company of Thyrocare with effective from February 27, 2024
Thyrocare Technologies informs about appointment of chief commercial officer
Thyrocare Tech. reports Profit after tax of Rs 148.90 Mln, in the December 2023 quarter
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Technologies to acquire 100% stake in Think Health
With this acquisition, the Company aims to enter into a new line of business of offering ECG testing services at home
Thyrocare Technologies informs about outcome of board meeting
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. reports Profit after tax of Rs 202.90 Mln, in the September 2023 quarter
Thyrocare Technologies enters into Subscription Agreement with Kastipharm
The JV company is incorporated as a part of long term business plans of the company on expansion of company’s existing business of providing diagnostics services in different geographies
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. reports Profit after tax of Rs 167.30 Mln, in the June 2023 quarter
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Technologies informs about disclosure
Thyrocare Technologies informs about disclosure
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. reports Profit after tax of Rs 99.30 Mln, in the March 2023 quarter
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Technologies informs about conference call
Thyrocare Technologies informs about analyst meet
Thyrocare Technologies submits analyst meet intimation
Thyrocare Technologies informs about disclosure
Thyrocare Technologies informs about investors meet
Thyrocare Technologies informs about audio recording of earning call
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Tech. - Quaterly Results
Thyrocare Technologies informs about disclosure of related party transactions
Thyrocare Technologies informs about investor presentation
Thyrocare Technologies to make investment of Rs 2.55 crore in Pulse Hitech Health Services
The Company, at its Board Meeting held on November 11, 2022, has approved the same